Annual report pursuant to Section 13 and 15(d)

Convertible Series A Preferred Stock and Warrant Offering (Details Narrative)

v3.21.1
Convertible Series A Preferred Stock and Warrant Offering (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Aug. 14, 2019
Jul. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Aug. 15, 2019
Apr. 11, 2019
Warrant to purchase of common stock     1,965,594      
Number of share warrants granted to issue   1,910,594 4,630,654 10,386,181    
Warrant exercise price     $ 1.10      
Series A Preferred Stock and Warrants [Member]            
Proceeds from issuance of preferred shares and warrants $ 4,688,000          
Direct costs of issuance 342,000          
Warrants [Member]            
Direct costs of issuance       $ 1,485,000    
Derivative liability 6,173,000          
Reduction to additional paid in capital $ 4,688,000          
Common Stock [Member]            
Number of shares issued, shares     4,237,833      
Warrant to purchase of common stock         3,245,162 163,739
Warrant exercise price         $ 1.88 $ 3.76
Conversion of stock, number of shares issued     1,768,909 409,032    
Securities Purchase Agreement [Member]            
Warrant to purchase of common stock 3,870,000          
Warrant exercise price $ 1.88          
Securities Purchase Agreement [Member] | Series A Preferred Stock and Warrants [Member]            
At-the-market agreement terms, description We are also prohibited, until the date that the Preferred Purchasers no longer collectively hold at least 20% of the then-outstanding shares of Series A Preferred Stock issued pursuant to the SPA, from entering into an agreement to effect any issuance by us of Common Stock or Common Stock equivalents involving certain variable rate transactions. We also cannot enter into agreements related to "at-the-market" transactions for a period of 12 months. At the later of (i) the date that the August Warrants are fully exercised, and (ii) 12 months from the date of the SPA, we cannot draw down on any existing or future agreement with respect to "at-the-market" transactions if the sale of the shares in such transactions has a per share purchase price that is less than $3.76 (two times the exercise price of the Warrants).          
Preferred stock conversion, description Each share of Series A Preferred Stock is convertible, at any time and from time to time from and after the issuance date, at the holder's option in to that number of shares of Common Stock equal to the stated value per share (or $1,000) divided by the conversion price (initially, $1.55); thus, initially, each share of Series A Preferred Stock is convertible into approximately 645 shares of Common Stock. In certain circumstances, the Series A Preferred Stock is mandatorily convertible into shares of Common Stock after the Company obtains stockholder approval to issue a number of shares of Common Stock in excess of 19.99% and the closing price of the Common Stock is 100% greater than the then-base conversion price on each trading day for any 20 trading days during a consecutive 30-trading-day period.          
Conversion price per share $ 1.55          
Shareholders' approval percentage for mandatory conversion 19.99%          
Number of common stock to be issued causing ineligibility to issue common stock 4,459,725          
Securities Purchase Agreement [Member] | Maximum [Member]            
Number of share warrants granted to issue 3,245,162          
Series A Preferred Shares [Member]            
Number of shares issued, shares 5,030          
Series A Preferred Shares [Member] | Securities Purchase Agreement [Member]            
Number of shares issued, shares 6,000          
Series A Convertible Preferred Stock [Member]            
Warrants to purchase shares of common stock     2,303,861      
Common stock, value, outstanding     $ 3,951,000      
Conversion of stock, number of shares issued     2,390 634    
Preferred stock, shares outstanding     2,006 4,396